Efficacy evaluation of a commercially available MCT enriched therapeutic diet on dogs with idiopathic epilepsy treated with zonisamide: a prospective, randomized, double-blinded, placebo-controlled, crossover dietary preliminary study
Open Access
- 6 September 2023
- journal article
- research article
- Published by Springer Nature in BMC Veterinary Research
- Vol. 19 (1) , 1-10
Abstract
Background: Idiopathic epilepsy (IE) is a common, chronic brain dysfunction in dogs. Recently, the effect of feeding a diet enriched with medium-chain triglycerides (MCTs) on seizure frequency has been evaluated in several studies in dogs with IE. However, most dogs with IE in previous studies were treated with phenobarbital as the main antiseizure medication (ASM). In Japan, zonisamide (ZNS) is the most prescribed ASM for dogs with IE. The interaction between ZNS and various nutrients including MCTs and the potential effects on treatment efficacy resulting from combining these therapies have not been previously studied. A prospective, randomized, double-blinded, placebo-controlled, crossover dietary study was conducted. Dogs (n = 7) treated with ZNS were fed either a placebo diet (PL) or Purina ProPlan Veterinary Diet NeuroCare (NC) for 3 months, after which treatments were crossed over and continued for another 3 months. Seizure frequency (seizures/month; sz/m), blood tests including concentrations of ZNS and β-hydroxybutyric acid, and owner’s visual analogue scale score were collected from all dogs for both treatment periods. Results: There was no significant difference in the seizure frequency between PL (2.95 ± 0.80 sz/m) and NC (1.90 ± 0.57 sz/m) during the 6 months of trial. Three of 7 dogs showed ≥ 50% seizure reduction, and 1 of those 3 dogs achieved seizure freedom in NC period. However, 2 of 7 dogs had no changes in epileptic seizure frequency, 2 of 7 dogs had a deterioration in seizure frequency in the NC period. Feeding the MCT diet concurrent with ZNS showed no apparent adverse effects and did not affect ZNS concentration. Conclusions: This study indicated that the commercially available MCT-enriched diet (NC) can be safely used concurrently with ZNS for dogs with IE.Keywords
Funding Information
- Nestlé Purina Japan marketing
This publication has 44 references indexed in Scilit:
- Public perception of epilepsy in dogs is more favorable than in humansEpilepsy & Behavior, 2013
- Prevalence and risk factors for canine epilepsy of unknown origin in the UKVeterinary Record, 2013
- Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonistActa Neurologica Scandinavica, 2013
- AMPA receptors as a molecular target in epilepsy therapyActa Neurologica Scandinavica, 2013
- Changes in glucose metabolism and metabolites during the epileptogenic process in the lithium‐pilocarpine model of epilepsyEpilepsia, 2012
- Longitudinal Changes in Cortical Glucose Hypometabolism in Children With Intractable EpilepsyJournal of Child Neurology, 2006
- Zonisamide: chemistry, mechanism of action, and pharmacokineticsSeizure: European Journal of Epilepsy, 2004
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- Seizures: Classification, etiologies, and pathophysiologyClinical Techniques in Small Animal Practice, 1998
- Successful surgical removal of an epileptogenic focus in a dogJournal of Small Animal Practice, 1971